Limited Research

Lipo-C

Lipotropic Injection | MIC + B Vitamins

Lipo-C is a lipotropic injection containing Methionine, Inositol, Choline (MIC), and B vitamins that support fat metabolism and liver function. These nutrients act as methyl donors and lipotropic agents, assisting in the breakdown and transport of fats. While individual components have documented metabolic roles, clinical evidence for the combined injection specifically for weight loss remains limited.

Daily dose

1-2 mL

Frequency

1-2x per week

Cycle length

4-12 weeks

Storage

Room temp or refrigerated

Key benefits

Lipotropic nutrients support liver function and fat metabolism. B vitamins contribute to energy metabolism. Pre-mixed injectable bypasses digestive absorption.

How it works

MIC components (methionine, inositol, choline) act as methyl donors and lipotropic agents supporting liver detoxification and lipid transport. Clinical evidence for weight loss from MIC injections specifically is limited.

Dosage protocols

Goal

General wellness

Dose

1 mL · 1x weekly

Route

IM or SubQ

Goal

Weight management

Dose

1-2 mL · 1-2x weekly

Route

IM or SubQ

Research indications

metabolic Health

Liver Function Support — Choline is essential for preventing fatty liver. Lipotropic nutrients support healthy hepatic lipid processing.

Methylation Support — Methionine and choline serve as methyl donors, supporting SAMe production and liver detoxification.

Insulin Sensitivity — Inositol has moderate evidence for improving insulin sensitivity, particularly in PCOS.

fat Loss

Fat Metabolism Support — Lipotropic agents assist in fat breakdown and transport. Direct evidence for weight loss from MIC injections is limited.

Modest Effects — If weight loss occurs with lipotropic injections, it is likely primarily due to accompanying diet and exercise.

energy Metabolism

B12 for Energy — B12 may improve energy in deficient individuals. No benefit above adequate levels.

Nutrient Delivery — Injectable delivery bypasses GI absorption, beneficial for those with malabsorption issues.

Administration

injectable

Interactions

Compatible

Semaglutide — Some clinics combine lipotropics with GLP-1 agonists for weight management. Different mechanisms - lipotropics support liver metabolism while GLP-1s affect appetite and glucose.

Compatible

Tirzepatide — May be used alongside GLP-1/GIP agonists in medical weight loss programs. Lipotropics provide nutritional support rather than hormonal effects.

Monitor Combination

B12 Supplements — Lipo-C already contains B12. Additional supplementation may be unnecessary and could lead to excessive intake.

Compatible

Metformin — No known interactions. Inositol component may provide complementary insulin sensitivity support.

Monitor Combination

Diabetes Medications — If Lipo-C formulation contains weight loss medications (semaglutide, etc.), blood glucose monitoring required to prevent hypoglycemia.

Use Caution

MAOIs — Inositol component may influence brain chemistry. Caution advised with monoamine oxidase inhibitors and psychiatric medications.

Safety notes

Clinical evidence for weight loss from MIC injections is limited

FDA does not regulate compounded injections

Formulations vary between providers - no standard formula

Requires prescription from licensed provider

Use only from reputable compounding pharmacies

Research studies

Choline Deficiency and Fatty Liver - Zeisel et al.

Human | Low-choline diets | Variable duration | Fatty liver and liver damage

Demonstrated that humans consuming diets low in choline develop fatty liver and hepatic damage, establishing choline's essential role in liver lipid metabolism.

View study →

Myo-Inositol for PCOS - Systematic Review (2023)

Meta-analysis | Multiple RCTs | PCOS patients | Improved insulin sensitivity

Systematic review found inositol effective for insulin sensitivity in PCOS, with improvements in fasting insulin and metabolic markers, though guidelines note evidence remains 'limited and inconclusive.'

View study →

L-Carnitine Weight Loss Meta-Analysis (2020)

37 RCTs | Various populations | Modest effect | -1.21 kg body weight

Meta-analysis of 37 randomized controlled trials showed L-carnitine supplementation resulted in modest but significant weight loss (-1.21 kg) and fat mass reduction (-2.08 kg), primarily when combined with exercise.

View study →

Myo-Inositol Metabolic Effects - Meta-Analysis (2017)

9 RCTs | PCOS patients | Decreased fasting insulin and HOMA index

Meta-analysis demonstrated significant decreases in fasting insulin, HOMA index, and improvements in lipid profiles (triglycerides, total and LDL cholesterol) with myo-inositol supplementation.

View study →

Choline and Inositol in Liver Fat - Animal Study

Rats | Aerobically trained | Reduced liver fat (6.69% vs 9.22%)

Study in aerobically trained rats showed the experimental group receiving choline and inositol had significantly less liver fat accumulation compared to controls.

View study →

Related compounds

L-Carnitine Fat Blaster AOD-9604 5-Amino-1MQ